We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
story of the week

Journal Scan / Research · September 10, 2020

Combined SGLT2 Inhibitors and Loop Diuretics in T2D Patients With CHF

Circulation

 

Additional Info

Circulation
Renal and Cardiovascular Effects of SGLT2 Inhibition in Combination With Loop Diuretics in Patients With Type 2 Diabetes and Chronic Heart Failure: The RECEDE-CHF Trial
Circulation 2020 Aug 29;[EPub Ahead of Print], NA Mordi, IR Mordi, JS Singh, RJ McCrimmon, AD Struthers, CC Lang

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading